Farnum Rhonda — SEC insider filings

SEC reporting owner CIK 1898490. 39 insider filings on record with FilingPulse; latest filed 2026-09-24.

Transaction summary — filings shown

Covers all 39 filings on record, filed 2021-12-16 to 2026-09-24. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Theravance Biopharma, Inc. (TBPH)SVP, COMM & MEDICAL AFFAIRS39—27 legs · 152,428 sh · $2,119,50528

Insider filings — Farnum Rhonda

FiledFormIssuerReported transactionsSource
2026-09-244Theravance Biopharma, Inc. (TBPH)Disposition to issuer (D): 124,414 · Disposition to issuer (D): 89,062 · Disposition to issuer (D): 150,000 (derivative)EDGAR
2026-09-174Theravance Biopharma, Inc. (TBPH)Sale (S): 3,329 @ $17.03 · Sale (S): 3,328 @ $17.03 · Sale (S): 6,657 @ $17.03EDGAR
2026-08-244Theravance Biopharma, Inc. (TBPH)Tax withholding (F): 5,667 @ $16.95EDGAR
2026-06-174Theravance Biopharma, Inc. (TBPH)Sale (S): 3,329 @ $16.39 · Sale (S): 3,328 @ $16.38 · Sale (S): 6,657 @ $16.39EDGAR
2026-05-224Theravance Biopharma, Inc. (TBPH)Tax withholding (F): 5,678 @ $16.55EDGAR
2026-04-034Theravance Biopharma, Inc. (TBPH)Grant/award (A): 18,750 @ $0EDGAR
2026-03-184Theravance Biopharma, Inc. (TBPH)Sale (S): 7,767 @ $13.92 · Sale (S): 15,534 @ $14 · Sale (S): 7,766 @ $13.92EDGAR
2026-02-244Theravance Biopharma, Inc. (TBPH)Tax withholding (F): 13,929 @ $19.66EDGAR
2025-12-054Theravance Biopharma, Inc. (TBPH)Sale (S): 7,767 @ $18.75 · Sale (S): 7,766 @ $18.75 · Sale (S): 15,534 @ $18.75EDGAR
2025-11-244Theravance Biopharma, Inc. (TBPH)Tax withholding (F): 9,060 @ $17.90EDGAR
2025-08-224Theravance Biopharma, Inc. (TBPH)Tax withholding (F): 9,096 @ $13.39EDGAR
2025-07-164Theravance Biopharma, Inc. (TBPH)Sale (S): 682 @ $11.39 · Sale (S): 5,318 @ $11.39 · Sale (S): 4,000 @ $11.39EDGAR
2025-06-044Theravance Biopharma, Inc. (TBPH)Sale (S): 24,000 @ $11EDGAR
2025-05-224Theravance Biopharma, Inc. (TBPH)Tax withholding (F): 9,120 @ $9.45EDGAR
2025-04-234Theravance Biopharma, Inc. (TBPH)Sale (S): 4,000 @ $9EDGAR
2025-03-044Theravance Biopharma, Inc. (TBPH)Grant/award (A): 75,000 @ $0EDGAR
2025-02-244Theravance Biopharma, Inc. (TBPH)Grant/award (A): 5,283 @ $0 · Tax withholding (F): 15,810 @ $9.66EDGAR
2025-01-234Theravance Biopharma, Inc. (TBPH)Sale (S): 4,000 @ $9EDGAR
2024-11-224Theravance Biopharma, Inc. (TBPH)Tax withholding (F): 9,178 @ $9.97EDGAR
2024-11-134Theravance Biopharma, Inc. (TBPH)Sale (S): 4,000 @ $9EDGAR
2024-08-224Theravance Biopharma, Inc. (TBPH)Tax withholding (F): 9,222 @ $8.22EDGAR
2024-07-124Theravance Biopharma, Inc. (TBPH)Sale (S): 4,000 @ $9EDGAR
2024-05-224Theravance Biopharma, Inc. (TBPH)Tax withholding (F): 9,268 @ $9.10EDGAR
2024-04-044Theravance Biopharma, Inc. (TBPH)Grant/award (A): 37,500 @ $0EDGAR
2024-02-224Theravance Biopharma, Inc. (TBPH)Tax withholding (F): 18,219 @ $8.92 · Sale (S): 1,254 @ $8.71EDGAR
2023-11-224Theravance Biopharma, Inc. (TBPH)Tax withholding (F): 7,982 @ $10.37 · Sale (S): 1,378 @ $10.29EDGAR
2023-08-244Theravance Biopharma, Inc. (TBPH)Sale (S): 1,807 @ $9.47EDGAR
2023-08-224Theravance Biopharma, Inc. (TBPH)Tax withholding (F): 10,460 @ $9.70EDGAR
2023-06-124Theravance Biopharma, Inc. (TBPH)Sale (S): 1,790 @ $11.13EDGAR
2023-05-234Theravance Biopharma, Inc. (TBPH)Tax withholding (F): 5,567 @ $11.21EDGAR
2023-03-134Theravance Biopharma, Inc. (TBPH)Sale (S): 4,000 @ $10.20EDGAR
2023-03-034Theravance Biopharma, Inc. (TBPH)Grant/award (A): 75,000 @ $0EDGAR
2023-02-224Theravance Biopharma, Inc. (TBPH)Tax withholding (F): 7,119 @ $10.44EDGAR
2022-11-224Theravance Biopharma, Inc. (TBPH)Tax withholding (F): 23,268 @ $10.85EDGAR
2022-08-234Theravance Biopharma, Inc. (TBPH)Tax withholding (F): 10,413 @ $9.34EDGAR
2022-05-244Theravance Biopharma, Inc. (TBPH)Tax withholding (F): 2,200 @ $8.74 · Sale (S): 1,081 @ $8.93EDGAR
2022-03-024Theravance Biopharma, Inc. (TBPH)Sale (S): 2,356 @ $10.16EDGAR
2022-02-234Theravance Biopharma, Inc. (TBPH)Tax withholding (F): 11,824 @ $9.61EDGAR
2021-12-164Theravance Biopharma, Inc. (TBPH)Grant/award (A): 27,500 @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2021-12-08 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1898490 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs